Sandbox WWC11: Difference between revisions

Revision as of 21:22, 29 April 2016 view source Dana Emmert (talk \| contribs) 734 edits No edit summary ← Older edit		Revision as of 14:37, 2 May 2016 view source Dana Emmert (talk \| contribs) 734 edits No edit summary Newer edit →
Line 43:		Line 43:

	'''Implication of Potential Defects or Deficiencies'''		'''Implication of Potential Defects or Deficiencies'''
			Individuals with myeloperoxidase deficiency have been found to have a slight increased risk of chronic or severe infection. However, this condition is not fatal and the body seems to be able to compensate with other immune system mechanisms. <ref name="ANCA">PMID:11111115</ref> The most common source of MPO deficiency is ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis (AAV). This is an autoimmune disease that causes the production of antibodies for enzymes like MPO. <ref name="ANCA">PMID:26986103</ref> However, these diseases have also been found to be link to a decrease in risk of cardiovascular disease.<ref name="ANCA">PMID:11111115</ref>

Navigation menu